Clinical Trials & Medical Discoveries Headlines from PR Newswire

< Go Back

Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Japanese Global Health Fund Awards $33.5 Million in Grant Investments in Less Than a Year to Develop Vaccines and Drugs for Neglected Diseases
NeuroDerm Ltd. Files Registration Statement for Proposed Initial Public Offering
Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis
REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density
First European Patients Enrolled in QT Vascular's ENDURE Trial
Paradigm-Heart Failure a Possible Alternative to ACE Inhibitors
Lupus Research Institute Launches NYC's First Lupus Trials Fair
Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids
Fluoride's Brain Damage Studies Mounting
Clinical Trials May Lead to Worse Medicine, Scientist Writes
Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device
Microarray technology proves superior to sequencing for non-invasive prenatal testing Spanish
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease
Scripps Offers Insights into Nation's First All Pencil-Beam Proton Center
Oramed to Present at Family Office & Wealth Management Conference
Shire Announces FDA Acceptance for Filing with Priority Review of Supplemental New Drug Application (sNDA) for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) for Adults with Binge Eating Disorder
Retina Implant AG's International Clinical Results Presented for the First Time in Europe Spanish
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure
ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014
Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)
Merck KGaA Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer
Lilly Announces CYRAMZA™ Phase III Second-Line Colorectal Cancer Trial Meets Primary Endpoint of Overall Survival
UT Southwestern researchers discover novel class of NAMPT activators for neurodegenerative disease; Calico enters into exclusive collaboration with 2M to develop UTSW technology
VolitionRx NuQ(R) Blood Test Detects 84% of Colorectal Cancers; Including Both Early- and Later-stage Cancers
Claritas Genomics Launches Next Generation Sequencing Panel to Detect Genetic Causes of Nephrotic Syndrome in Children
RXi Pharmaceuticals Presented an Update on the Company's Dermatology and Ophthalmology Franchises
Takeda and Orexigen Announce FDA Approval of Contrave® (naltrexone HCI and bupropion HCI) Extended-release Tablets for Chronic Weight Management
Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer
Prosonix Confirms the Potential of its Multi-Component Particle™ Technology for Developing Novel Inhaled Dual and Triple Combination Therapies for Respiratory Diseases
AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease
Genomic analysis reveals that a high-risk leukemia subtype becomes more common with age
U.S. FDA Approves New Indication for the Use of XTANDI® (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer
Pivotal Announces Publication of a Clinical Trial Showing Beneficial Effects of VASCAZEN® In The Correction of Omega-3 Deficiency In Cardiovascular Patients
Reporting Bias in Clinical Trials: What's the current status?
Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting
Blueprint Medicines Discovers Novel Cancer Drug Targets
MabVax Therapeutics Enters Agreements with Memorial Sloan Kettering Cancer Center and Juno Therapeutics for Development of Anti-Cancer Therapeutics
Neodyne Biosciences Data Now Published in Plastic & Reconstructive Surgery Shows Long-Term Effectiveness of the EMBRACE® Device in Reducing Scar Formation
Relmada Announces The Filing Of Clinical Trial Application In Canada For d-methadone
Beta-O2 Receives Grant from JDRF to Advance Clinical Development of the ßAir Bio-artificial Pancreas as a Potential Cure for Type 1 Diabetes English
Harpoon Medical, Inc. Announces $3.75M Series A Financing
AcelRx Announces Publication of Manuscript Analyzing Cost of Intravenous Patient-Controlled Analgesia with Opioids
American Society of Hematology Endorses New NHLBI Report on Sickle Cell Disease
Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial English
Bleachers, Us The Duo And Bea Miller Join Pitbull & All-Star Lineup At T.J. Martell Foundation's 15th Annual Family Day Honoring RCA Records' Tom Corson And Family Spanish
EMD Serono Presents New Data on Rebif ® (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston
SRI International and Nobelpharma Co., Ltd., Partner on Endometriosis Drug Development

< Prev Next >
PR Newswire - United Business Media